Dolutegravir Pharmacokinetics in the Genital Tract and Colorectum of HIV Negative Men After Single and Multiple Dosing

OBJECTIVES: To describe first dose and steady-state pharmacokinetics (PK) of dolutegravir (DTG) in blood plasma (BP), seminal fluid (SF), colorectal tissue (RT), and rectal mucosal fluid (RF) of healthy HIV negative men. DESIGN: A Phase 1, open label, PK study that enrolled 12 healthy men taking DTG...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Greener, Benjamin N, Patterson, Kristine B, Prince, Heather MA, Sykes, Craig, Adams, Jessica L, Dumond, Julie B, Shaheen, Nicholas J, Madanick, Ryan D, Dellon, Evan S, Cohen, Myron S, Kashuba, Angela DM
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804901/
https://ncbi.nlm.nih.gov/pubmed/23945251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31829ed7a4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares